Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kosugi, Nobuharu
LUNA3, NCT04562766 / 2020-002063-60: Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)	Active, not recruiting	3	194	Europe, Canada, Japan, US, RoW	Rilzabrutinib, PRN1008, Placebo, PRN1008 Placebo	Principia Biopharma, a Sanofi Company, Principia Biopharma, Inc.	Immune Thrombocytopenia	06/25	11/26
Horikiri, Yasuyo
LUNA3, NCT04562766 / 2020-002063-60: Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP)	Active, not recruiting	3	194	Europe, Canada, Japan, US, RoW	Rilzabrutinib, PRN1008, Placebo, PRN1008 Placebo	Principia Biopharma, a Sanofi Company, Principia Biopharma, Inc.	Immune Thrombocytopenia	06/25	11/26